Healthcare & Medical Devices Global On demand · 24-48h

Global Bionic Prosthetics and Mechanical Exoskeletons Market Strategic Research Report

Global Bionic Prosthetics and Mechanical Exoskeletons Market…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Bionic Prosthetics and Mechanical Exoskeletons Market
$3242025
24%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Upper Limbs, Lower Limbs, Whole Body, Others

By Application: Military, Civilian, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Sarcos Robotics, Ekso Bionics, Lifeward, Cyberdyne, Synchron, Open Bionics, SuitX, Touch Bionics, Marsi Bionics, Exii, Ottobock, Esper Bionics, Xilloc Medical, Mobius Bionics, Coapt, Blatchford, FAULHABER GROUP, Hocoma, Fourier Intelligence, FREE Bionics Taiwan Inc., Guangzhou Shipeng Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 164 pages
Market size 2025
$324
Million USD
Forecast CAGR
24%
2025-2032
Forecast 2032
$1460.5
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Bionic Prosthetics and Mechanical Exoskeletons market size is predicted to grow from US$ 324 million in 2025 to US$ 1,425 million in 2032; it is expected to grow at a CAGR of 24.0% from 2026 to 2032.

Bionic prosthetics and mechanical exoskeletons are products that apply high-tech and robotic technologies to provide important functional recovery and auxiliary support for amputees, people with disabilities, and people who need assistance. Bionic prosthetics are artificial limbs that combine sensors, motors and control systems, and feedback systems to simulate human limb movement and function. Mechanical exoskeletons are external wearable devices that provide additional strength, support, and protection to the human body through external structures. Bionic prosthetics and mechanical exoskeletons have a wide range of applications in military, civilian, rehabilitation and medical fields, including assisting people with motor impairment to restore their ability to hold objects and walk, reducing artificial weight, and transporting materials.

Global key Bionic Prosthetics and Mechanical Exoskeletons players cover Sarcos Robotics, Ekso Bionics, Lifeward, Cyberdyne, Synchron, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bionic Prosthetics and Mechanical Exoskeletons market?

What factors are driving Bionic Prosthetics and Mechanical Exoskeletons market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bionic Prosthetics and Mechanical Exoskeletons market opportunities vary by end market size?

How does Bionic Prosthetics and Mechanical Exoskeletons break out by Type, by Application?

This report presents a comprehensive overview of the global Bionic Prosthetics and Mechanical Exoskeletons market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Upper Limbs
  • Lower Limbs
  • Whole Body
  • Others

Segment by Application

  • Military
  • Civilian
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Bionic Prosthetics and Mechanical Exoskeletons market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Military, Civilian, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Bionic Prosthetics and Mechanical Exoskeletons Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 24%
Regional growth momentum
Market share by segment
Key metrics
Base value
$324
2025
Forecast
$1460.5
2032
CAGR
24%
2025–2032
Regiones
5
global
Key companies
Sarcos RoboticsEkso BionicsLifewardCyberdyneSynchronOpen BionicsSuitXTouch Bionics
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Upper LimbsLower LimbsWhole BodyOthers
By Application
MilitaryCivilianOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Upper Limbs
  • 3.1.3 Lower Limbs
  • 3.1.4 Whole Body
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Military
  • 4.1.3 Civilian
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Sarcos Robotics
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Ekso Bionics
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Lifeward
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Cyberdyne
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Synchron
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Open Bionics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SuitX
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Touch Bionics
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Marsi Bionics
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Exii
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Ottobock
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Esper Bionics
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Xilloc Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Mobius Bionics
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Coapt
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Blatchford
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 FAULHABER GROUP
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Hocoma
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Fourier Intelligence
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 FREE Bionics Taiwan Inc.
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Guangzhou Shipeng Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Bionic Prosthetics and Mechanical Exoskeletons market?
The global Bionic Prosthetics and Mechanical Exoskeletons market is estimated at US$ 324 million in 2025 (base year) and is projected to reach US$ 1.43 billion by 2032.
What is the forecast CAGR for the Bionic Prosthetics and Mechanical Exoskeletons market?
The market is expected to grow at a CAGR of 24.0% from 2026 to 2032, expanding from US$ 324 million in 2025 to US$ 1.43 billion in 2032, roughly 4.4 times its base-year value.
What is Bionic Prosthetics and Mechanical Exoskeletons?
Bionic prosthetics and mechanical exoskeletons are products that apply high-tech and robotic technologies to provide important functional recovery and auxiliary support for amputees, people with disabilities, and people who need assistance. Bionic prosthetics are artificial limbs that combine sensors, motors and control systems, and feedback systems to simulate human limb movement and function. Mechanical exoskeletons are external wearable devices that provide additional strength, support, and protection to the human body through external structures.
What are the main segments of the Bionic Prosthetics and Mechanical Exoskeletons market by type?
By type, the market is segmented into Upper Limbs, Lower Limbs, Whole Body and Others.
Which applications drive demand in the Bionic Prosthetics and Mechanical Exoskeletons market?
Key applications covered include Military, Civilian and Others.
Who are the key players in the Bionic Prosthetics and Mechanical Exoskeletons market?
Key players profiled include Sarcos Robotics, Ekso Bionics, Lifeward, Cyberdyne, Synchron, Open Bionics, SuitX and Touch Bionics, among 21 companies covered in total.
Which regions and countries are covered for Bionic Prosthetics and Mechanical Exoskeletons?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Bionic Prosthetics and Mechanical Exoskeletons market?
What factors are driving Bionic Prosthetics and Mechanical Exoskeletons market growth, globally and by region?
Who should buy the Bionic Prosthetics and Mechanical Exoskeletons market report?
The report is intended for manufacturers and solution providers, distributors and end users in Military, Civilian and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Bionic Prosthetics and Mechanical Exoskeletons market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.